{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:45:40Z","timestamp":1791395140215,"version":"4.3.3"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    We have previously shown that the expression of nicotinamide\n                    <jats:italic>N<\/jats:italic>\n                    -methyltransferase (NNMT) is significantly increased in the brains of patients who have died of Parkinson\u2019s disease (PD). In this study, we have compared the expression of NNMT in post-mortem medial temporal lobe, hippocampus and cerebellum of 10 Alzheimer\u2019s disease (AD) and 9 non-disease control subjects using a combination of quantitative Western blotting, immunohistochemistry and dual-label confocal microscopy coupled with quantitative analysis of colocalisation. NNMT was detected as a single protein of 29\u00a0kDa in both AD and non-disease control brains, which was significantly increased in AD medial temporal lobe compared to non-disease controls (7.5-fold,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.026). There was no significant difference in expression in the cerebellum (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.91). NNMT expression in AD medial temporal lobe and hippocampus was present in cholinergic neurones with no glial localisation. Cell-type expression was identical in both non-disease control and AD tissues. These results are the first to show, in a proof-of-concept study using a small patient cohort, that NNMT protein expression is increased in the AD brain and is present in neurones which degenerate in AD. These results suggest that the elevation of NNMT may be a common feature of many neurodegenerative diseases. Confirmation of this overexpression using a larger AD patient cohort will drive the future development of NNMT-targetting therapeutics which may slow or stop the disease pathogenesis, in contrast to current therapies which solely address AD symptoms.\n                  <\/jats:p>","DOI":"10.1007\/s12035-020-02259-9","type":"journal-article","created":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T06:03:07Z","timestamp":1609567387000},"page":"1769-1781","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["High Expression of Nicotinamide N-Methyltransferase in Patients with Sporadic Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"58","author":[{"given":"Altin","family":"Kocinaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabassum","family":"Chaudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashad R.","family":"Junaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Ramsden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geshanthi","family":"Hondhamuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio","family":"Klamt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5618-3780","authenticated-orcid":false,"given":"Richard B.","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,2]]},"reference":[{"key":"2259_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","volume":"25","author":"CA Lane","year":"2018","unstructured":"Lane CA, Hardy J, Schott JM (2018) Alzheimer\u2019s disease. Eur J Neurol 25:59\u201370","journal-title":"Eur J Neurol"},{"key":"2259_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00401-009-0536-x","volume":"118","author":"T Arendt","year":"2009","unstructured":"Arendt T (2009) Synaptic degeneration in Alzheimer\u2019s disease. Acta Neuropathol 118:167\u2013179","journal-title":"Acta Neuropathol"},{"key":"2259_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.conb.2017.12.017","volume":"48","author":"E Marcello","year":"2018","unstructured":"Marcello E, Di Luca M, Gardoni F (2018) Synapse-to-nucleus communication: from developmental disorders to Alzheimer\u2019s disease. Curr Opin Neurobiol 48:160\u2013166","journal-title":"Curr Opin Neurobiol"},{"key":"2259_CR4","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s10571-017-0574-1","volume":"38","author":"FP Chong","year":"2018","unstructured":"Chong FP, Ng KY, Koh RY, Chye SM (2018) Tau proteins and tauopathies in Alzheimer\u2019s disease. Cell Mol Neurobiol 38:965\u2013980","journal-title":"Cell Mol Neurobiol"},{"key":"2259_CR5","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1515\/revneuro-2017-0063","volume":"29","author":"AB Reiss","year":"2018","unstructured":"Reiss AB, Arain HA, Stecker MM, Slegart NM, Kasselman LJ (2018) Amyloid toxicity in Alzheimer\u2019s disease. Rev Neurosci 29:613\u2013627","journal-title":"Rev Neurosci"},{"key":"2259_CR6","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3233\/JAD-180766","volume":"67","author":"JL Cummings","year":"2019","unstructured":"Cummings JL, Tong G, Ballard C (2019) Treatment combinations for Alzheimer\u2019s disease: current and future pharmacotherapy options. J Alzheimers Dis 67:779\u2013794","journal-title":"J Alzheimers Dis"},{"key":"2259_CR7","doi-asserted-by":"publisher","first-page":"14835","DOI":"10.1016\/S0021-9258(17)36700-5","volume":"269","author":"S Aksoy","year":"1994","unstructured":"Aksoy S, Szumlanski CL, Weinshilboum RM (1994) Human liver nicotinamide N-methyltransferase. cDNA cloning, expression and biochemical characterisation. J Biol Chem 269:14835\u201314840","journal-title":"J Biol Chem"},{"key":"2259_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/jnen\/61.2.111","volume":"61","author":"RB Parsons","year":"2002","unstructured":"Parsons RB, Smith M-L, Waring RH, Williams AC, Ramsden DB (2002) Expression of nicotinamide N-methyltransferase (NNMT, E.C. 2.1.1.1) in the Parkinsonian brain. J Neuropathol Exp Neurol 61:111\u2013124","journal-title":"J Neuropathol Exp Neurol"},{"key":"2259_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0304-3940(03)00218-0","volume":"342","author":"RB Parsons","year":"2003","unstructured":"Parsons RB, Smith SW, Waring RH, Williams AC, Ramsden DB (2003) High expression of nicotinamide N-methyltransferase in patients with idiopathic Parkinson\u2019s disease. Neurosci Lett 342:13\u201316","journal-title":"Neurosci Lett"},{"key":"2259_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1042\/BJ20101685","volume":"436","author":"RB Parsons","year":"2011","unstructured":"Parsons RB, Aravindan S, Kadampeswaran A, Evans EA, Sadhu KK, Levy ER et al (2011) The expression of nicotinamide N-methyltransferase increases ATP synthesis and protects SH-SY5Y neuroblastoma cells against the toxicity of complex I inhibitors. Biochem J 436:145\u2013155","journal-title":"Biochem J"},{"key":"2259_CR11","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/jbt.21508","volume":"27","author":"ZH Milani","year":"2013","unstructured":"Milani ZH, Ramsden DB, Parsons RB (2013) Neuroprotective effects of nicotinamide N-methyltransferase and its metabolite 1-methylnicotinamide. J Biochem Mol Toxicol 27:451\u2013456","journal-title":"J Biochem Mol Toxicol"},{"key":"2259_CR12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.bbrc.2015.10.023","volume":"467","author":"KY Liu","year":"2015","unstructured":"Liu KY, Mistry RJ, Aguirre CA, Fasouli ES, Thomas MG, Klamt F, Ramsden DB, Parsons RB (2015) Nicotinamide N-methyltransferase increases complex I activity in SH-SY5Y cells via Sirtuin 3. Biochem Biophys Res Commun 467:491\u2013496","journal-title":"Biochem Biophys Res Commun"},{"key":"2259_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.200","volume":"4","author":"MG Thomas","year":"2013","unstructured":"Thomas MG, Saldanha M, Mistry RJ, Dexter DT, Ramsden DB, Parsons RB (2013) Nicotinamide N-methyltransferase expression in SH-SY5Y neuroblastoma and N27 mesencephalic neurones induces changes in cell morphology via ephrin-B2 and Akt signalling. Cell Death Dis 4:e669","journal-title":"Cell Death Dis"},{"key":"2259_CR14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.nrl.2016.02.016","volume":"32","author":"H Niu","year":"2017","unstructured":"Niu H, Alvarez-Alvarez I, Guillen-Grima F, Arguinaga-Ontoso I (2017) Prevalence and incidence of Alzheimer\u2019s disease in Europe: a meta-analysis. Neurologia 32:523\u2013532","journal-title":"Neurologia"},{"key":"2259_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41582-018-0032-9","volume":"14","author":"MT Ferretti","year":"2018","unstructured":"Ferretti MT, Iulita MF, Cavedo E, Chiesa PA, Schumacher Dimech A, Santuccione Chadha A et al (2018) Sex differences in Alzheimer\u2019s disease \u2013 the gateway to precision medicine. Nat Rev Neurol 14:457\u2013469","journal-title":"Nat Rev Neurol"},{"key":"2259_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1178646917691739","volume":"10","author":"DB Ramsden","year":"2017","unstructured":"Ramsden DB, Waring RH, Barlow DJ, Parsons RB (2017) Nicotinamide N-methyltransferase in health and disease, with special reference to cancer. Int J Tryptophan Res 10:1\u201319","journal-title":"Int J Tryptophan Res"},{"key":"2259_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1178646920919770","volume":"13","author":"DB Ramsden","year":"2020","unstructured":"Ramsden DB, Waring RH, Parsons RB, Barlow DJ, Williams AC (2020) Nicotinamide N-methyltransferase: genomic connection to disease. Int J Tryptophan Res 13:1\u201315","journal-title":"Int J Tryptophan Res"},{"key":"2259_CR18","doi-asserted-by":"publisher","first-page":"15764","DOI":"10.1038\/s41598-018-33592-8","volume":"8","author":"W Stauffer","year":"2018","unstructured":"Stauffer W, Sheng H, Lim HN (2018) EzColocalization: an ImageJ plugin for visualising and measuring colocalization in cells and organisms. Sci Rep 8:15764","journal-title":"Sci Rep"},{"key":"2259_CR19","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1242\/bio.019893","volume":"5","author":"H Sheng","year":"2016","unstructured":"Sheng H, Stauffer W, Lim HN (2016) Systematic and general method for quantifying localization in microscopy images. Biol Open 5:1882\u20131893","journal-title":"Biol Open"},{"key":"2259_CR20","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1529\/biophysj.103.038422","volume":"86","author":"SV Costes","year":"2004","unstructured":"Costes SV, Daelemans D, Cho EW, Dobbin Z, Pavlakis G, Lockett S (2004) Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys J 86:3993\u20134003","journal-title":"Biophys J"},{"key":"2259_CR21","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1365-2818.1993.tb03313.x","volume":"169","author":"EMM Manders","year":"1993","unstructured":"Manders EMM, Verbeek FJ, Aten JA (1993) A measurement of colocalization of objects in dual-colour confocal images. J Microsc 169:375\u2013382","journal-title":"J Microsc"},{"key":"2259_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-94-007-5416-4_14","volume":"65","author":"VJ De Paula","year":"2012","unstructured":"De Paula VJ, Radanovic M, Diniz BS, Forlenza OV (2012) Alzheimer\u2019s disease. Subcell Biochem 65:329\u2013352","journal-title":"Subcell Biochem"},{"key":"2259_CR23","first-page":"11","volume":"197","author":"K Andersen","year":"2012","unstructured":"Andersen K, Andersen BB, Pakkenberg B (2012) Stereological quantification of the cerebellum in patients with Alzheimer\u2019s disease. Neurobiol Aging 197:11\u201320","journal-title":"Neurobiol Aging"},{"key":"2259_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/mp.2017.246","volume":"23","author":"KE Hopperton","year":"2018","unstructured":"Hopperton KE, Mohammad D, Trepanier MO, Giuliano V, Bazinet RP (2018) Markers of microglia in post-mortem brain samples from patients with Alzheimer\u2019s disease: a systematic review. Mol Psychiatry 23:177\u2013198","journal-title":"Mol Psychiatry"},{"key":"2259_CR25","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1002\/hbm.23580","volume":"38","author":"H Tabatabaei-Jafari","year":"2017","unstructured":"Tabatabaei-Jafari H, Walsh E, Shaw ME, Cherbuin N (2017) The cerebellum shrinks faster than normal ageing in Alzheimer\u2019s disease but not mild cognitive impairment. Hum Brain Mapp 38:3141\u20133150","journal-title":"Hum Brain Mapp"},{"key":"2259_CR26","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/carcin\/bgq225","volume":"32","author":"SW Tang","year":"2011","unstructured":"Tang SW, Yang TC, Lin WC, Chang WH, Wang CC, Lai MK, Lin JY (2011) Nicotinamide N-methyltransferase induces cellular invasion through activating matrix metalloprotease-2 expression in clear cell renal cell carcinoma cells. Carcinogenesis. 32:138\u2013145","journal-title":"Carcinogenesis."},{"key":"2259_CR27","doi-asserted-by":"crossref","unstructured":"Sartini D, Muzzonigro G, Milanese G, Pozzi V, Vici A, Morganti S, Rossi V, Mazzucchelli R et al (2013) Upregulation of tissue and urinary nicotinamide N-methyltransferase in bladder cancer: potential for the development of a urine-based diagnostic test. Cell Biochem Biophys 65:473\u2013483","DOI":"10.1007\/s12013-012-9451-1"},{"key":"2259_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/CMR.0000000000000548","volume":"29","author":"M Mascitti","year":"2019","unstructured":"Mascitti M, Santarelli A, Sartini D, Rubini C, Colella G, Salvolini E, Ganzetti G, Offidani A et al (2019) Analysis of nicotinamide N-methyltransferase in oral malignant melanoma and potential prognostic significance. Melanoma Res 29:151\u2013156","journal-title":"Melanoma Res"},{"key":"2259_CR29","doi-asserted-by":"publisher","first-page":"e22439","DOI":"10.1002\/jbt.22439","volume":"34","author":"RJ Mistry","year":"2020","unstructured":"Mistry RJ, Klamt F, Ramsden DB, Parsons RB (2020) Nicotinamide N-methyltransferase expression in SH-SY5Y human neuroblastoma cells decreases oxidative stress. J Biochem Mol Toxicol 34:e22439","journal-title":"J Biochem Mol Toxicol"},{"key":"2259_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.21037\/biotarget.2019.11.01","volume":"3","author":"RB Parsons","year":"2019","unstructured":"Parsons RB (2019) Nicotinamide N-methyltransferase and metastasis: a new player in cancer therapeutics. Biotarget. 3:20","journal-title":"Biotarget."},{"key":"2259_CR31","doi-asserted-by":"publisher","first-page":"102995","DOI":"10.1016\/j.critrevonc.2020.102995","volume":"153","author":"IJ Bristot","year":"2020","unstructured":"Bristot IJ, Dias CK, Chapola H, Parsons RB, Klamt F (2020) Metabolic rewiring in drug-resistant melanoma cells. Crit Rev Oncol Hematol 153:102995","journal-title":"Crit Rev Oncol Hematol"},{"key":"2259_CR32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/nature13198","volume":"508","author":"D Kraus","year":"2014","unstructured":"Kraus D, Yang Q, Kong D, Banks AS, Zhang L, Rodgers JT, Pirinen E, Pulinilkunnil TC et al (2014) Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature. 508:258\u2013262","journal-title":"Nature."},{"key":"2259_CR33","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.cmet.2015.07.017","volume":"22","author":"SAJ Trammer","year":"2018","unstructured":"Trammer SAJ, Brenner C (2018) NNMT: a bad actor in fat makes good in liver. Cell Metab 22:200\u2013201","journal-title":"Cell Metab"},{"key":"2259_CR34","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bcp.2017.11.007","volume":"147","author":"H Neelakantan","year":"2018","unstructured":"Neelakantan H, Vance V, Wetzel MD, Wang HL, McHardy SF, Finnerty CC et al (2018) Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. Biochem Pharmacol 147:141\u2013152","journal-title":"Biochem Pharmacol"},{"key":"2259_CR35","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1038\/s41598-018-22081-7","volume":"8","author":"A Kannt","year":"2018","unstructured":"Kannt A, Rajagopal S, Kadnur SV, Suresh J, Bhamidipati RK, Swaminathan S, Hallur MS, Kristam R et al (2018) A small molecule inhibitor of nicotinamide N-methyltransferase for the treatment of metabolic disorders. Sci Rep 8:3660","journal-title":"Sci Rep"},{"key":"2259_CR36","first-page":"33","volume":"20","author":"Q Hu","year":"2020","unstructured":"Hu Q, Liu F, Yang L, Fang Z, He J, Wang W et al (2020) Lower serum nicotinamide N-methyltransferase levels in patients with bipolar disorder during acute episodes compared to healthy controls: a cross-sectional study. BCM Psychiatry 20:33","journal-title":"BCM Psychiatry"},{"key":"2259_CR37","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1017\/S1461145711001179","volume":"15","author":"A Bromberg","year":"2012","unstructured":"Bromberg A, Lerer E, Udawela M, Scarr E, Dean B, Belmaker RH, Ebstein R, Agam G (2012) Nicotinamide N-methyltransferase (NNMT) in schizophrenia: genetic association and decreased frontal cortex mRNA levels. Int J Neuropsychopharmacol 15:727\u2013737","journal-title":"Int J Neuropsychopharmacol"},{"key":"2259_CR38","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.clinbiochem.2007.06.001","volume":"40","author":"AO Akanji","year":"2007","unstructured":"Akanji AO, Ohaeri JU, Al-Shammri SA, Fatania HR (2007) Associations of blood homocysteine concentrations in Arab schizophrenic patients. Clin Biochem 40:1026\u20131031","journal-title":"Clin Biochem"},{"key":"2259_CR39","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.7150\/ijms.9426","volume":"11","author":"GX Wang","year":"2014","unstructured":"Wang GX, Zhang Y, Lv ZW, Sun M, Wu D, Chen XY, Wu YM (2014) Female specific association between NNMT gene and schizophrenia in a Han Chinese population. Int J Med Sci 11:1234\u20131239","journal-title":"Int J Med Sci"},{"key":"2259_CR40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.arr.2019.02.006","volume":"51","author":"F Zhou","year":"2019","unstructured":"Zhou F, Chen S (2019) Hyperhomocysteinemia and risk of incident cognitive outcomes: an updated dose-response meta-analysis of prospective cohort studies. Ageing Res Rev 51:55\u201366","journal-title":"Ageing Res Rev"},{"key":"2259_CR41","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1086\/430409","volume":"76","author":"JC Souto","year":"2005","unstructured":"Souto JC, Blanco-Vaca F, Soria JM, Buil A, Almasy L, Ordonex-Llanos J et al (2005) A genomewide exploration suggests a new candidate gene at chromosome 11q23 as the major determinant of plasma homocysteine levels: results from the GAIT project. Am J Hum Genet 76:925\u2013933","journal-title":"Am J Hum Genet"},{"key":"2259_CR42","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.atherosclerosis.2008.09.015","volume":"204","author":"M Riederer","year":"2009","unstructured":"Riederer M, Erwa W, Zimmermann R, Frank S, Zechner R (2009) Adipose tissue as a source of nicotinamide N-methyltransferase and homocysteine. Atherosclerosis 204:412\u2013417","journal-title":"Atherosclerosis"},{"key":"2259_CR43","doi-asserted-by":"publisher","first-page":"243.e7","DOI":"10.1016\/j.neurobiolaging.2017.09.033","volume":"62","author":"T Roostai","year":"2018","unstructured":"Roostai T, Felsky D, Nazeri A, De Jager PL, Schneider JA, Bennett DA et al (2018) Genetic influence of plasma homocysteine on Alzheimer\u2019s disease. Neurobiol Aging 62:243.e7\u2013243.14","journal-title":"Neurobiol Aging"},{"key":"2259_CR44","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.neurobiolaging.2018.08.028","volume":"76","author":"DJ Lehman","year":"2019","unstructured":"Lehman DJ, Cortina-Borja M (2019) Genetic influence of plasma homocysteine on Alzheimer\u2019s disease. Neurobiol Aging 76:217\u2013218","journal-title":"Neurobiol Aging"},{"key":"2259_CR45","doi-asserted-by":"publisher","first-page":"34088","DOI":"10.1074\/jbc.M111.243907","volume":"286","author":"J Olah","year":"2011","unstructured":"Olah J, Vincze O, Virok D, Simon D, Bozso Z, Tokesi N et al (2011) Interactions of pathological hallmark proteins: tubulin polymerisation promoting protein\/p25, beta-amyloid, and alpha-synuclein. J Biol Chem 286:34088\u201334100","journal-title":"J Biol Chem"},{"key":"2259_CR46","doi-asserted-by":"publisher","first-page":"e1007661","DOI":"10.1371\/journal.pgen.1007561","volume":"14","author":"K Schmeisser","year":"2018","unstructured":"Schmeisser K, Parker JA (2018) Nicotinamide N-methyltransferase controls behaviour, neurodegeneration and lifespan by regulating neuronal autophagy. PLoS Genet 14:e1007661","journal-title":"PLoS Genet"},{"key":"2259_CR47","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nchembio.1352","volume":"9","author":"J Schmeisser","year":"2013","unstructured":"Schmeisser J, Mansfeld J, Kuhlow D, Weimer S, Priebe S, Heiland I et al (2013) Role of sirtuins in lifespan regulation is linked to methylation of nicotinamide. Nat Chem Biol 9:693\u2013700","journal-title":"Nat Chem Biol"},{"key":"2259_CR48","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1734-1140(10)70304-2","volume":"62","author":"M Sternak","year":"2010","unstructured":"Sternak M, Khomoch TI, Jakubowski M, Szafarz W, Szczepanski W, Bialas M et al (2010) Nicotinamide N-methyltransferase (NNMT) and 1-methynicotinamide (MNA) in experimental hepatitis induces by concavalin A in the mouse. Pharmacol Rep 62:483\u2013483","journal-title":"Pharmacol Rep"},{"key":"2259_CR49","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1164\/rccm.200906-0936OC","volume":"181","author":"HC Kim","year":"2010","unstructured":"Kim HC, Mofarrahi M, Vassilakopoulos T, Malrais F, Sigala I, Debigare R et al (2010) Expression and functional significance of nicotinamide N-methyltransferase in skeletal muscle of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 181:797\u2013805","journal-title":"Am J Respir Crit Care Med"},{"key":"2259_CR50","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/sj.bjp.0707383","volume":"152","author":"S Chlopicki","year":"2007","unstructured":"Chlopicki S, Swies K, Mogielnicki A, Buczko W, Bartus M, Lomnicka M (2007) 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thromotic activity mediated by a cyclooxygenase-2\/prostacyclin pathway. Br J Pharmacol 152:230\u2013239","journal-title":"Br J Pharmacol"},{"key":"2259_CR51","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/j.1572-0241.2001.03698.x","volume":"96","author":"R Pumpo","year":"2001","unstructured":"Pumpo R, Sarnelli G, Spinella A, Budillon G, Cuomo R (2001) The metabolism of nicotinamide in human cirrhosis: a study on N-methylnicotinamide and 2-pyridone-5-carboxamide production. Am J Gastroenterol 96:1183\u20131187","journal-title":"Am J Gastroenterol"},{"key":"2259_CR52","doi-asserted-by":"publisher","first-page":"e91980","DOI":"10.1172\/jci.insight.91980","volume":"3","author":"N Tankiki","year":"2018","unstructured":"Tankiki N, Nakamoto N, Chu PS, Mikami Y, Amiya T, Teratani T et al (2018) Intestinal barrier regulates immune responses in the liver via IL-10-producing macrophages. JCI Insight 3:e91980","journal-title":"JCI Insight"},{"key":"2259_CR53","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000452486","volume":"7","author":"TL Michaud Michaud","year":"2017","unstructured":"Michaud Michaud TL, Su D, Siahpush M, Murman DL (2017) The risk of incident mild cognitive impairment and progression to dementia considering mild cognitive impairment subtypes. Dement Geriatr Cogn Dis Extra 7:15\u201329","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"2259_CR54","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak Braak","year":"1991","unstructured":"Braak Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"2259_CR55","first-page":"17","volume":"53","author":"AM Graybiel Graybiel","year":"1990","unstructured":"Graybiel Graybiel AM, Hirsch EC, Agid Y (1990) The nigrostriatal system in Parkinson\u2019s disease. Adv Neurol 53:17\u201329","journal-title":"Adv Neurol"},{"key":"2259_CR56","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3233\/JAD-170543","volume":"62","author":"DA Butterfield","year":"2018","unstructured":"Butterfield DA, Boyd-Kimball D (2018) Oxidative stress, amyloid-\u03b2 peptide, and altered key molecular pathways in the pathogenesis and progression of Alzheimer\u2019s disease. J Alzheimers Dis 62:1345\u20131367","journal-title":"J Alzheimers Dis"},{"key":"2259_CR57","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1006\/nbdi.1999.0241","volume":"6","author":"C Pereira","year":"1999","unstructured":"Pereira C, Santos MS, Oliveira C (1999) Involvement of oxidative stress on the impairment of energy metabolism induced by A beta peptides on PC12 cells: protection by antioxidants. Neurobiol Dis 6:209\u2013219","journal-title":"Neurobiol Dis"},{"issue":"Suppl. 1","key":"2259_CR58","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/jnc.13425","volume":"139","author":"AA Belaidi","year":"2016","unstructured":"Belaidi AA, Bush AI (2016) Iron neurochemistry in Alzheimer\u2019s disease and Parkinson\u2019s disease: targets for therapeutics. J Neurochem 139(Suppl. 1):179\u2013197","journal-title":"J Neurochem"},{"key":"2259_CR59","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/j.1471-4159.2004.02438.x","volume":"89","author":"SM Cardoso","year":"2004","unstructured":"Cardoso SM, Santana I, Swerdlow RH, Oliveira CR (2004) Mitochondria dysfunction of Alzheimer\u2019s disease cybrids enhances Abeta toxicity. J Neurochem 89:1417\u20131426","journal-title":"J Neurochem"},{"key":"2259_CR60","first-page":"570","volume":"3","author":"RX Santos","year":"2010","unstructured":"Santos RX, Correia SC, Wang X, Perry G, Smith MA, Moreira PI et al (2010) Alzheimer\u2019s disease: diverse aspects of mitochondrial malfunctioning. Int J Clin Exp Pathol 3:570\u2013581","journal-title":"Int J Clin Exp Pathol"},{"key":"2259_CR61","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/j.1471-4159.1992.tb09439.x","volume":"59","author":"SJ Kish","year":"1992","unstructured":"Kish SJ, Bergeron C, Rajput A, Dozic S, Mastrogiacomo F, Chang LJ, Wilson JM, DiStefano LM et al (1992) Brain cytochrome oxidase in Alzheimer\u2019s disease. J Neurochem 59:776\u2013779","journal-title":"J Neurochem"},{"key":"2259_CR62","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1046\/j.1471-4159.1994.63062179.x","volume":"63","author":"EM Mutisya","year":"1994","unstructured":"Mutisya EM, Bowling AC, Beal MF (1994) Cortical cytochrome oxidase activity is reduced in Alzheimer\u2019s disease. J Neurochem 63:2179\u20132184","journal-title":"J Neurochem"},{"key":"2259_CR63","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3892\/ijmm.2016.2833","volume":"39","author":"N Nakano","year":"2017","unstructured":"Nakano N, Matsuda S, Ichimura M, Minami A, Ogino M, Murai T et al (2017) PI3\/Akt signalling mediated by G protein-coupled receptors is involved in neurodegenerative Parkinson\u2019s disease. Int J Mol Med 39:253\u2013260","journal-title":"Int J Mol Med"},{"key":"2259_CR64","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1016\/j.cellsig.2014.08.019","volume":"26","author":"D Heras-Sandoval","year":"2014","unstructured":"Heras-Sandoval D, Perez-Rojas JM, Hernandez-Damian J, Pedraza-Chaverri J (2014) The role of PI3K\/Akt\/mTor pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell Signal 26:2694\u20132701","journal-title":"Cell Signal"},{"key":"2259_CR65","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s12031-017-0991-0","volume":"63","author":"J Zhang","year":"2017","unstructured":"Zhang J, Shu Y, Qu Y, Zhang L, Chu T, Zheng Y, Zhao H (2017) C-myb plays an essential role in the protective function of IGF-1 on cytotoxicity induced by A\u03b225-35 via the PI3K\/Akt pathway. J Mol Neurosci 63:412\u2013418","journal-title":"J Mol Neurosci"},{"key":"2259_CR66","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s12640-019-0003-y","volume":"35","author":"SN Rai","year":"2019","unstructured":"Rai SN, Dilnashin H, Birla H, Singh SS, Zahra W, Rathore AS, Singh BK, Singh SP (2019) The role of PI3\/Akt and ERK in neurodegenerative disorders. Neurotox Res 35:775\u2013795","journal-title":"Neurotox Res"},{"issue":"Suppl. 1","key":"2259_CR67","first-page":"S141","volume":"33","author":"F Hernandez","year":"2013","unstructured":"Hernandez F, Lucas JJ, Avila J (2013) GSK3 and Tau: two convergence points in Alzheimer\u2019s disease. J Alzheimers Dis 33(Suppl. 1):S141\u2013S144","journal-title":"J Alzheimers Dis"},{"key":"2259_CR68","first-page":"C273","volume":"300","author":"KW Dunn","year":"2011","unstructured":"Dunn KW, Kamocka MM, McDonald KH (2011) A practical guide to evaluating colocalization in biological microscopy. Am J Phys Cell Phys 300:C273\u2013C242","journal-title":"Am J Phys Cell Phys"},{"key":"2259_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201965","volume":"13","author":"RP Theart","year":"2018","unstructured":"Theart RP, Loos B, Powrie YSL, Niesler TR (2018) Improved region of interest selection and colocalization analysis in three-dimensional fluorescence microscopy samples using virtual reality. PLoS One 13:e0201965","journal-title":"PLoS One"},{"key":"2259_CR70","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.1039\/C7OB01357D","volume":"15","author":"MJ van Haren","year":"2017","unstructured":"van Haren MJ, Taig R, Kuppens J, Torano JS, Moret EE, Parsons RB et al (2017) Inhibitors of nicotinamide N-methyltransferase designed to mimic the methylation reaction transition state. Org Biomol Chem 15:6656\u20136667","journal-title":"Org Biomol Chem"},{"key":"2259_CR71","doi-asserted-by":"publisher","first-page":"6597","DOI":"10.1021\/acs.jmedchem.9b00413","volume":"62","author":"Y Gao","year":"2019","unstructured":"Gao Y, van Haren MJ, Moret EE, Rood JJM, Sartini D, Salvucci A, Emanuelli M, Craveur P et al (2019) Bisubtrate inhibitors of nicotinamide N-methyltransferase (NNMT) with enhanced activity. J Med Chem 62:6597\u20136614","journal-title":"J Med Chem"},{"key":"2259_CR72","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.bmcl.2018.01.058","volume":"28","author":"S Ruf","year":"2018","unstructured":"Ruf S, Hallur MS, Anchan NK, Swamy IN, Murugesan KR, Sarkar S, Narasimhulu LK, Putta VPRK et al (2018) Novel nicotinamide analog as inhibitor of nicotinamide N-methyltransferase. Bioorg Med Chem Lett 28:922\u2013925","journal-title":"Bioorg Med Chem Lett"},{"key":"2259_CR73","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/15548627.2015.1017192","volume":"11","author":"L You","year":"2015","unstructured":"You L, Wang Z, Li H, Shou J, Jibg Z, Xie J et al (2015) The role of STAT3 in autophagy. Autophagy. 11:729\u2013739","journal-title":"Autophagy."},{"key":"2259_CR74","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3233\/JAD-2009-1048","volume":"17","author":"L Wang","year":"2009","unstructured":"Wang L, Xu S, Xu X, Chan P (2009) (-)-Epigallocatechin-3-gallate protects SH-SY5Y cells against 6-OHDA-induced cell death through STAT3 activation. J Alzheimers Dis 17:295\u2013304","journal-title":"J Alzheimers Dis"},{"key":"2259_CR75","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1039\/C5OB00052A","volume":"13","author":"J Mantaj","year":"2015","unstructured":"Mantaj J, Rahman AM, Bokshi B, Hasan CM, Jackson PJM, Parsons RB et al (2015) Crispene E, a cis-clerodane diterpene inhibits STAT3 dimerization in breast cancer cells. Org Biomol Chem 13:3882\u20133886","journal-title":"Org Biomol Chem"},{"key":"2259_CR76","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s11481-018-09830-1","volume":"14","author":"L Fu","year":"2019","unstructured":"Fu L, Liu C, Chen L, Lv Y, Meng G, Hu M, Long Y, Hong H et al (2019) Protective effects of 1-methylnicotinamde on A\u03b2(1-42)-induced cognitive defecits, neuroinflammation and apoptosis in mice. J NeuroImmune Pharmacol 14:401\u2013412","journal-title":"J NeuroImmune Pharmacol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-02259-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-020-02259-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-02259-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T09:14:02Z","timestamp":1614849242000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-020-02259-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,2]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["2259"],"URL":"https:\/\/doi.org\/10.1007\/s12035-020-02259-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,2]]},"assertion":[{"value":"20 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Ethical permission for the use of post-mortem human tissue in this study was obtained from the NHS Research Authority NRES Committee London \u2013 Central (REC# 08\/H0718\/54+5).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}